Scientific breakthrough. Russia begins testing a unique cancer vaccine

According to his statement, the research is being conducted at the National Medical Research Center for Radiology, which was the first to receive approval for the initial phase of an open-label, single-center clinical trial.

Forty-eight volunteers will participate in the drug testing. Kaprin emphasized that the medication has extremely low toxicity, indicating its safety.

He also noted that last year, 25 new oncology drugs were registered worldwide, writes Gazeta.ru.

«Russia is also actively developing this field: several cancer vaccines are being developed in the country, including «Enteromix,» created jointly by specialists from the National Medical Research Center for Radiology and the Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences. Work is also underway on a personalized mRNA vaccine—a joint project of the National Medical Research Center for Radiology and the Gamaleya Research Center,» the scientist concluded.